Posts tagged BioCryst Pharmaceuticals Inc.


Here’s Why BioCryst Pharmaceuticals, Inc. (BCRX) Shares Popped Today

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) investors cheer the news that the FDA has approved the supplemental …

Here’s Why BioCryst Pharmaceuticals, Inc. (BCRX) Skyrocket Today

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) investors have a smile on their faces Thursday morning, after the …

H.C. Wainwright Maintains Buy On BioCryst Pharmaceuticals, Inc. (BCRX) Following 1Q:16 Update

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares slipped yesterday 9% after the drug discovery company reportedĀ first-quarter results …

Biotech Beat: Oppenheimer Analysts Weigh In on Sarepta Therapeutics, Inc. (SRPT) and BioCryst Pharmaceuticals (BCRX)

Oppenheimer analysts express mixed sentiments on Sarepta Therapeutics, Inc. (NASDAQ:SRPT) and BioCryst Pharmaceuticals (NASDAQ:BCRX) as …

Piper Jaffray Weighs In on Two Collapsing Biotechs: CTI BioPharma Corp (CTIC), BioCryst Pharmaceuticals, Inc. (BCRX)

Piper Jaffray’s healthcare analyst Charles DuncanĀ is weighing in today on biotech companies CTI BioPharma Corp …

Stock Update (NASDAQ:BCRX): BioCryst Pharmaceuticals, Inc. Announces Clinical Results in Hereditary Angioedema

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced results from OPuS-2 (Oral ProphylaxiS-2), a clinical trial of avoralstat …

Company Update (NASDAQ:BCRX): BioCryst Pharmaceuticals, Inc. Reports 2Q:15 Financial Results

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced financial results for the second quarter ended June 30, 2015. …

Show More